GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Actavia Life Sciences RASP · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Actavia Life Sciences — daily RASP Delayed
Market value
$289,008
Last close × shares
Volume
20
Shares, 30 Oct 2026

About Actavia Life Sciences

Its shares trade under the ticker RASP. It has been listed since 28 March 2014. In the fiscal year to 30 September 2014, it reported revenue of −$350 and a net loss of $40,035. At that date it held total assets of $6,685 and shareholders' equity of $5,705.

Rasna Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development of therapeutics for the treatment of leukemia and lymphoma diseases. The company is headquartered in New York City, New York. The company went IPO on 2014-03-28. The firm is focused on the development of disease-modifying drugs candidates for leukemia and lymphoma. The firm is targeting nucleophosmin (NPM1)-mutated acute myeloid leukemi (AML) through direct and indirect disease-modifying approaches. AML includes acute and chronic. The company is also exploring inhibition of lysine specific demethylase-1 (LSD1), an enzyme involved in epigenetic control, as approach against AML. The Company’s product candidate includes RASP-101, RASP-201 and RASP-301. RASP-101 is an anticancer therapeutic for treating NPM1 mutated acute myeloid leukemia (AML). Formulation of RASP-101 is being developed to conduct multi-center clinical trials in NPM1 mutated AML patients.

Figures and description from our data supplier, not checked against the company's own report.

More about Actavia Life Sciences →

Latest on Actavia Life Sciences

Our reporting

We have not reported on Actavia Life Sciences yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Actavia Life Sciences's ticker?

Actavia Life Sciences trades as RASP on its US listing, under ISIN US7538881068.

What was Actavia Life Sciences's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.